newsfilter
← Latest News
Business Wire·

Viridian Therapeutics Announces Royalty Financing with DRI Healthcare for up to $300 Million

- Viridian receives $55 million upfront and potential near-term milestones up to $115 million based on positive VRDN-003 topline data and U.S. veligrotug marketing approval - - Upfront and anticipated near-term